...
机译:下一代测序分析未选择性中药乳腺癌患者的BRCA1 / 2突变谱和患病率
Cent S Univ State Key Lab Med Genet 172 Tongzipo Rd Changsha 410013 Hunan Peoples R China;
Sanway Gene Technol Inc Changsha 410205 Hunan Peoples R China;
Cent S Univ Xiangya Hosp Dept Breast Surg Changsha 410008 Hunan Peoples R China;
Sanway Gene Technol Inc Changsha 410205 Hunan Peoples R China;
Sanway Gene Technol Inc Changsha 410205 Hunan Peoples R China;
Sanway Gene Technol Inc Changsha 410205 Hunan Peoples R China;
Sanway Gene Technol Inc Changsha 410205 Hunan Peoples R China;
Cent S Univ Xiangya Hosp Dept Breast Surg Changsha 410008 Hunan Peoples R China;
Cent S Univ Xiangya Hosp Dept Breast Surg Changsha 410008 Hunan Peoples R China;
Cent S Univ Xiangya Hosp 2 Dept Breast &
Thyroid Surg Changsha 410011 Hunan Peoples R China;
Sanway Gene Technol Inc Changsha 410205 Hunan Peoples R China;
Cent S Univ State Key Lab Med Genet 172 Tongzipo Rd Changsha 410013 Hunan Peoples R China;
Breast cancer; BRCA1; BRCA2; Mutation; Microfluidic PCR; Next-generation sequencing;
机译:下一代测序分析未选择性中药乳腺癌患者的BRCA1 / 2突变谱和患病率
机译:在中国2769例未选择性乳腺癌患者中BRCA1 / 2 BRCA1 / 2和PALB2 PALB2基因种系突变的患病率和临床结果
机译:中国BRCA突变和BRCA相关乳腺癌特征的光谱:下一代测序筛选2,991名患者和1,043名患者
机译:基于临床病理证据的中国家族性和散发性乳腺癌BRCA1有害突变全序列分析
机译:通过高通量测序确定患有乳腺癌家族史的非洲裔美国女性中的BRCA1突变和多态性。
机译:基于下一代测序的中国乳腺癌女性BRCA1 / 2种系突变的发生率和谱
机译:基于下一代测序的中国乳腺癌女性患有患有BRCA1 / 2种系突变的患病率和谱